Literature DB >> 9591784

Identification of domains of c-Jun mediating androgen receptor transactivation.

S C Wise1, L A Burmeister, X F Zhou, A Bubulya, J L Oberfield, M J Birrer, L Shemshedini.   

Abstract

The proto-oncoprotein c-Jun, when complexed with c-Fos, forms the climeric complex identified as AP-1 which regulates transcription directly by binding to AP-1-responsive genes. We have previously reported an indirect mechanism by which c-Jun is able to regulate transcription by stimulating androgen receptor transactivation in the absence of c-Fos or any apparent DNA binding. A series of c-Jun mutants were tested in order to characterize the domains of c-Jun responsible for this effect. The studies reported here indicate that a functional bZIP region and a portion of the N-terminal activation functions is necessary for c-Jun stimulation of androgen receptor transactivation. Testing c-Jun/v-Jun chimeras, we show that v-Jun is unable to stimulate androgen receptor transactivation and the effect is dependent on the c-Jun activation functions. c-Jun exhibits a bell-shaped activity on androgen receptor-mediated transactivation which appears to be distinct from c-Jun's transactivation ability. A c-Jun mutant deficient in transactivation is able to stimulate androgen receptor activity. These results indicate that c-Jun's transactivation ability can be separated from c-Jun's ability to stimulate the androgen receptor transactivation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591784     DOI: 10.1038/sj.onc.1201697

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.

Authors:  Weidong Yong; Zuocheng Yang; Sumudra Periyasamy; Hanying Chen; Selcul Yucel; Wei Li; Leanne Y Lin; Irene M Wolf; Martin J Cohn; Laurence S Baskin; Edwin R Sa Nchez; Weinian Shou
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

2.  Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.

Authors:  Huiqing Yuan; Charles Y F Young; Yuanyuan Tian; Zhifang Liu; Mengye Zhang; Hongxiang Lou
Journal:  Mol Cell Biochem       Date:  2010-02-11       Impact factor: 3.396

3.  Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription.

Authors:  Josephat Omwancha; Xiao-Feng Zhou; Shao-Yong Chen; Timour Baslan; Christopher J Fisher; Zhe Zheng; Changmeng Cai; Lirim Shemshedini
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

Authors:  JianFeng Zhang; Nan Gao; David J DeGraff; Xiuping Yu; Qian Sun; Thomas C Case; Susan Kasper; Robert J Matusik
Journal:  Prostate       Date:  2010-06-15       Impact factor: 4.104

5.  Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer.

Authors:  M T Abreu-Martin; A Chari; A A Palladino; N A Craft; C L Sawyers
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Transcriptional activity of c-Jun is critical for the suppression of AR function.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

Review 7.  Androgen receptor phosphorylation: biological context and functional consequences.

Authors:  Yulia Koryakina; Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-01-14       Impact factor: 5.678

8.  c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription.

Authors:  A Bubulya; X F Zhou; X Q Shen; C J Fisher; L Shemshedini
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.925

9.  c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation.

Authors:  K Tillman; J L Oberfield; X Q Shen; A Bubulya; L Shemshedini
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

10.  Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.

Authors:  R Mukherjee; D H McGuinness; P McCall; M A Underwood; M Seywright; C Orange; J Edwards
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.